.ANALYSIS HIGHLIGHT.06 August 2024.
A huge randomized measured test along with cisgender females highlights the obstacles of faithfulness to a regular oral preexposure prophylaxis routine and shows that twice-yearly treatment of lenacapavir may preserve reliable HIV avoidance amounts over 6 months.